We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Priveterra Acquisition Corporation II | NASDAQ:PMGMU | NASDAQ | Trust |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.96 | 8.99 | 13.21 | 0 | 01:00:00 |
AEON BIOPHARMA, INC.
5 PARK PLAZA, SUITE 1750
IRVINE, CA 92614
August 22, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: | Delaying Amendment for AEON Biopharma, Inc. |
Registration Statement on Form S-1 (File No. 333-274094)
Ladies and Gentlemen:
Reference is made to the Registration Statement on Form S-1 (File No. 333-274094) filed with the Securities and Exchange Commission (the “Commission”) by AEON Biopharma, Inc. on August 18, 2023 (the “Registration Statement”). Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated into the facing page of the Registration Statement:
“The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.”
No fees are required in connection with this filing. If you have any questions or comments in connection with this delaying amendment, please contact our legal counsel Drew Capurro, Latham & Watkins LLP, at (714) 755-8008.
Sincerely, | ||
AEON Biopharma, Inc. | ||
By: | /s/ Alex Wilson | |
Name: Alex Wilson | ||
Title: Chief Legal Officer & Corporate Secretary |
cc: Drew Capurro, Latham & Watkins LLP
B. Shayne Kennedy, Latham & Watkins LLP
1 Year Priveterra Acquisition C... Chart |
1 Month Priveterra Acquisition C... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions